Hemophagocytic lymphohistiocytosis (HLH) is a rare but fatal complication after solid organ transplantation. Acquired forms of HLH are described in association with severe sepsis, autoimmune disorders, malignancy, immune-compromised states, infections, and solid organ transplantation. We experienced a case of hemophagocytic lymphohistiocytosis after bilateral lung transplantation. Leukopenia, thrombocytopenia, and hyperbilirubinemia were noted and became aggravated 50 days after transplantation. Diagnosis of HLH was based on clinical and laboratory findings of splenomegaly, cytopenia, elevated ferritin, elevated interleukin-2 receptor, and hemophagocytosis in bone marrow. Other features such as elevated bilirubin, lactate dehydrogenase, and D-dimer which can be present in HLH were also noted. The patient was immediately treated with etoposide and dexamethasone. Despite aggressive therapy, the patient deteriorated and died. Awareness of the diagnostic criteria of HLH after lung transplantation is important for clinicians.
Microscopic finding from a bone marrow biopsy specimen ( Fig. 2A and Fig. 2B ) and immunohistochemical staining for CD68 (Fig. 2C) . The microscopic finding from the bone marrow biopsy specimen shows prominent hemosiderin deposition and multifocal fat necrosis with foamy macrophage infiltrates ( Fig. 2A [x100] and Fig. 2B [x400] ). Immunohistochemical staining for CD68 shows an increased number of stromal macrophages (Fig. 2C) . 
